Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Arcutis Biotherapeutics (ARQT)

Annual Return

Over the past 3 years, ARQT has had an average annual return of +36.44%, outperforming the benchmark SPY, which returned +22.77% annual.

Over the past 5 years, ARQT has had an average annual return of -4.66%, underperforming the benchmark SPY, which returned +14.05% annual.

Since Jan 31, 2020, ARQT has had an average annual return of -0.74%, underperforming the benchmark SPY, which returned +16.16% annual.

2026202520242023202220212020
-28.41%+108.47%+331.17%-78.17%-28.64%-26.27%+29.04%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-12.63%+6.31%-12.65%-1.44%-7.58%-3.12%-28.41%
2025-4.96%+3.41%+14.24%-4.67%-12.53%+7.51%+4%+6.44%+21.46%+34.27%+21.10%-5.26%+108.47%
2024+81.71%+75.12%-3.60%-16.04%+0.47%+11.24%+8.27%+8.05%-14.53%-10.64%+56.93%+6.82%+331.17%
2023+11.96%-2.35%-32.01%+25.82%-45.74%+26.91%+14.48%-21.74%-37.81%-57.64%-18.22%+75.59%-78.17%
2022-27.15%+17.80%+8.21%+4.82%+3.42%+2.06%+13.84%+11.09%-29.09%-7.48%-2.54%-14.11%-28.64%
2021-2.99%+25.21%-15.33%+15.79%-21.34%+3.57%-14.51%-9.26%+12.85%-11.34%-21.77%+25.17%-26.27%
2020+0%+21.90%+12.14%-0.27%+12.89%-9.86%-11.71%-6.11%+16.87%-39.18%+52.19%+3.73%+29.04%

Drawdown analysis of Arcutis Biotherapeutics (ARQT)

The maximum drawdown for the ARQT was -95.02%, occurring on Nov 30, 2023. This drawdown has not yet recovered.

The current ARQT drawdown is -43.78%.

Since Jan 31, 2020 ARQT has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 3 times
  • 20% or more: 3 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-95.02%Feb 8, 2021708Nov 30, 2023OngoingOngoingOngoing
-51.71%Mar 23, 2020155Oct 30, 202067Feb 8, 2021222
-39.41%Mar 10, 20206Mar 18, 20202Mar 20, 20208
-6.89%Feb 26, 20202Feb 28, 20207Mar 10, 20209
-4.63%Feb 24, 20201Feb 25, 20201Feb 26, 20202
-3.78%Feb 10, 20205Feb 18, 20201Feb 19, 20206
-3.50%Feb 4, 20202Feb 6, 20201Feb 7, 20203